ASCRS 2020: Intraocular dexamethasone, moxifloxacin vs topical regimen
May 20, 2020
Ophthalmology Times' David Hutton speaks with John A.
Alex Delaney-Gesing
How Ora will observe Clinical Trials Day this May 20
May 19, 2020
Jeanne Hecht, Ora chief executive officer, discusses the significance of clinical research as a care option with Sheryl Stevenson, Ophthalmology Times
ASCRS 2020: Kala virtual booth + dry eye product development
May 18, 2020
Ophthalmology Times' Sheryl Stevenson speaks with Kala Pharmaceuticals' James Yanek, director of professional relations, and Desiree Owen, OD, associate director of Medical Science Liaisons at
ASCRS 2020: Real-world efficacy of DEXYCU data retrospective case study
May 17, 2020
Ophthalmology Times' David Hutton speaks with Cynthia Matossian, MD, FACS, on her presentation "Real-world efficacy of DEXYCU (dexamethasone intraocular suspension) 9% retrospectiv
ASCRS 2020: BVI traces business evolution, advent of pre-loaded product
May 17, 2020
Ophthalmology Times' Sheryl Stevenson speaks with Shervin Korangy, president and CEO of BVI Medical, on the latest updates and products in the pipeline for the company, how they're assisting with and providing resources for healt
ASCRS 2020: Bio-Tissue posters focus on amniotic membrane
May 17, 2020
Ophthalmology Times' Sheryl Stevenson speaks with Roger Kennedy, director of marketing at Bio-Tissue, on the company's research posters presented at the 2020 ASCRS virtual meeting, as well as updates on operations amid the corona
ASCRS 2020: Assessing effectiveness of intracameral phenylephrine/ketorolac post-cataract surgery
May 16, 2020
Denise Visco, MD, speaks with Ophthalmology Times Executive Editor David Hutton on the findings from her poster on the effects of intracameral phenylephrine/ketorolac 1.0%/0.3% on postoperative
ASCRS 2020: Updates, improved injection technique from Eyepoint Pharmaceuticals
May 16, 2020
Ophthalmology Times' Sheryl Stevenson speaks with Eyepoint Pharmaceuticals' President/CEO Nancy Lurker and Chief Medical Officer Dario Paggiarino, MD, on the company's latest developments and research ahead of the ASCRS 2020 virt
ASCRS 2020: New solutions for patient, physician access from Sun Pharmaceuticals
May 16, 2020
Ophthalmology Times' Sheryl Stevenson speaks with Mark Hagler, senior vice president, head of Ophthalmics, Oncology & LTC at Sun Pharmaceuticals, on the company's ongoing research and portfolio, as well as how its operations
ASCRS 2020: Alcon research from biometer to trifocal to visualization
May 16, 2020
Ophthalmology Times' Sheryl Stevenson sits down with Kristen Brotherson, vice president of U.S.
